ArticleCancer medicine2025

Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Amanda Nizam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.